You are here

Liquid Form of Metformin Now Available

JACKSONVILLE, Fla., Feb. 10 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc., (RPI), a wholly-owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the nationwide availability of Riomet™ (metformin HCl oral solution) 500mg/5mL, the first and only liquid form of metformin on the market. Metformin is the number one prescribed oral treatment for Type 2 diabetes, the seventh leading cause of death in the United States.

Dr. Andrew Drexler, a leading New York City diabetologist and Associate Professor of the New York University School of Medicine, said, "I routinely prescribe metformin to my diabetes patients. Riomet™ will allow me to provide them with a liquid alternative of metformin, which may improve compliance among my patients who cannot or prefer not to swallow a pill. "

As a liquid form of metformin, Riomet™ may significantly improve the lives of people with diabetes who are unable to swallow tablets-a condition known as dysphagia. Dysphagia is a relatively unknown but widespread problem, affecting one in seventeen people in some form.

Jeffrey Thomas, vice president, brand marketing and sales at Ranbaxy USA Inc., an affiliate of RPI which provides primary marketing and promotion services to RPI, said, "Ranbaxy has recognized that non-compliance with treatment is a major problem among people with type 2 diabetes. For that reason, and the large number of people who have difficulty swallowing large tablets, Ranbaxy saw an opportunity for a liquid form of the top-selling diabetes drug metformin. By arming physicians with Riomet™, Ranbaxy is providing an alternative for the dsyphagic patient and those that are averse to taking a tablet, which may help to improve patient compliance."

Diabetes is a major health concern in the United States, where 6.3% of the population has the disease. And the risk increases with age-the incidence of diabetes among Americans age 60 and older is 18.3%. And older people are also at much higher risk of having difficulty swallowing pills-45% of seniors have dysphagia.

Type 2 diabetes is the most common form of the disease, affecting between 90 and 95% of all sufferers. In type 2 diabetes, insulin, which carries sugar from the blood into the body's cells, is either not produced by the body in sufficient quantities or is not accepted by the cells. This causes glucose to build up in the blood, which can starve the body's cells for energy and ultimately damage the eyes, kidneys, nerves and heart. In fact, two out of every three people with diabetes die of heart disease or stroke.

Source: Ranbaxy Pharmaceuticals Inc.

Recent Headlines

NY Hospitals Required to Implement Protocols in Suspected Cases
Presence of BOK Protein Key for Positive Treatment Response
Patient Access to Inhaler Use Data Could Improve Asthma Management
Overall Survival 4.3 Months’ vs. 1.5 Months for Traditional Regimens
Primary Immunodeficiencies Affect 250,000 People in U.S.
More Than 25% of Patients Responded to Xpovio/Dexamethasone Combo
Attacks Cancerous Cells, Leaves Healthy Tissues Alone
Moderates Pre-diabetes Progression, Reduces Cholesterol Levels